Susquehanna International Group’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49M Sell
715,829
-460,898
-39% -$1.75M ﹤0.01% 5660
2025
Q4
$4.08M Buy
1,176,727
+592,303
+101% +$2.63M ﹤0.01% 4349
2025
Q3
$3.24M Buy
584,424
+101,696
+21% +$413K ﹤0.01% 4829
2025
Q2
$1.19M Buy
482,728
+340,109
+238% +$524K ﹤0.01% 6989
2025
Q1
$284K Buy
142,619
+105,567
+285% +$269K ﹤0.01% 10174
2024
Q4
$108K Sell
37,052
-78,002
-68% -$274K ﹤0.01% 11279
2024
Q3
$445K Buy
115,054
+9,162
+9% +$42.4K ﹤0.01% 8749
2024
Q2
$544K Buy
105,892
+84,580
+397% +$513K ﹤0.01% 8065
2024
Q1
$149K Sell
21,312
-25,273
-54% -$192K ﹤0.01% 10908
2023
Q4
$413K Buy
+46,585
New +$359K ﹤0.01% 9114
2023
Q3
Sell
-12,254
Closed -$180K 12759
2023
Q2
$180K Buy
+12,254
New +$171K ﹤0.01% 10393

Other funds holding PRME